rs762556795
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000280904.11(DSC2):c.4G>A(p.Glu2Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000728 in 1,524,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000280904.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.4G>A | p.Glu2Lys | missense_variant | 1/16 | ENST00000280904.11 | NP_077740.1 | |
DSCAS | NR_110785.1 | n.136+245C>T | intron_variant, non_coding_transcript_variant | |||||
DSC2 | NM_004949.5 | c.4G>A | p.Glu2Lys | missense_variant | 1/17 | NP_004940.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.4G>A | p.Glu2Lys | missense_variant | 1/16 | 1 | NM_024422.6 | ENSP00000280904 | P1 | |
DSCAS | ENST00000581836.2 | n.152+245C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152036Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 14AN: 118124Hom.: 0 AF XY: 0.000169 AC XY: 11AN XY: 65148
GnomAD4 exome AF: 0.0000729 AC: 100AN: 1372118Hom.: 0 Cov.: 32 AF XY: 0.0000798 AC XY: 54AN XY: 676542
GnomAD4 genome AF: 0.0000724 AC: 11AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74246
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 11 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 10, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 2 of the DSC2 protein (p.Glu2Lys). This variant is present in population databases (rs762556795, gnomAD 0.03%). This missense change has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 20864495). ClinVar contains an entry for this variant (Variation ID: 199776). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 05, 2018 | The p.Glu2Lys variant (rs762556795) was reported in one patient with palpitation at 15 years age of onset without a family history (Christensen 2010). This variant is listed in the Genome Aggregation Database (gnomAD) with a population frequency of 0.02 percent in the European Non-Finnish population (identified on 12 out of 56,600 chromosomes) and has been reported to the ClinVar database (Variation ID: 199776). The glutamic acid at the second codon is weakly conserved and before the signal peptide which is cleaved off before insertion into the plasma membrane. Computational analyses of the p.Glu2Lys variant on protein structure and function provide conflicting results (SIFT: damaging, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.Glu2Lys variant with certainty. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 03, 2023 | This missense variant replaces glutamic acid with lysine at codon 2 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 26264440). This variant has been identified in 16/149434 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 29, 2023 | Reported in one Danish individual fulfilling task force criteria for a diagnosis of ARVC (PMID: 20864495); Identified in 15 individuals from a cohort of 30,716 predominantly European individuals undergoing exome sequencing and review of available electronic health records indicated that none of these individuals had a documented diagnosis of ARVC (PMID: 28471438), although specific clinical details and follow-up cardiac evaluations were not reported; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23911551, 26264440, 20864495, 31402444, 28471438) - |
Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Jan 11, 2024 | This missense variant replaces glutamic acid with lysine at codon 2 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 26264440). This variant has been identified in 16/149434 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at